Ocugen, Inc.
看多

OCGN - good buy, WHO approval waiting

214
Good buy at this price.

Waiting for WHO approval for Covid Vaccine, it's partially approved for emergency use in India.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。